Back to results

Ox1R agonists for the treatment of autoimmunity diseases

Patent Application number: European Procedure (Patents) (EPA) - 24 Juin 2014 - 14 305 990.5
Inventors:
MESSAL Nassima,OGIER-DENIS Eric,VOISIN Thierry,TRETON Xavier

Reference:

BIO14095-T1

Business Developper
contact
Inserm Transfert
Business Developer
Patent filling date: 24-06-2014
Rare disease: No
Second indication: No

You might also be interested in

RT00571

Hybridoma producing monoclonal antibodies against

[…]

Read more
RT00572

Hybridoma producing monoclonal antibodies against

[…]

Read more
RT00573

Hybridoma producing monoclonal antibodies against

[…]

Read more
RT00642

Galectin 3ko mouse (b6.cg-lgals3tm1poi/j)

This mouse model is available at Jackson Laboratories, Strain #:006338 […]

Read more
RT00724

Pmacs(ires-cd4) plasmids with 6 different inserts

pMACS(IRES-CD4) plasmids with 6 different inserts R13I, I12I, R10I, G9I, G9I without signal peptide, […]

Read more
RT00731

Umln hpr

[…]

Read more
RT00726

Dual vsv pseudotyped replicon for standardized

[…]

Read more
RT00578

Gfp expressing mutant rats

[…]

Read more
RT00247

Anti- beta- 1,2 linked oligomannoses (candida

Rat / mouse hybrid […]

Read more
RT00656

B6bc cell line

This murine cell line is the first syngenic hormone receptor-positive cell line of C57BL/6 strain. […]

Read more
RT00733

A breast-cancer cell line expressing a bret

We have developed a MCF7-derived cell line stably co-expressing the pleckstrin homology (PH) domain […]

Read more
RT00583

Meln (her alpha) cell line

MELN were generated by transfection of breasr cancer MCF-7 cells with the […]

Read more